A comprehensive view of Cellares integrated development and manufacturing. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Transformation & Innovation Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Bristol Myers Squibb enters into a US$380.0M deal with Cellares for the clinical and commercial-scale production of CAR T cell therapies; the companies to use Cellares' Cell Shuttle automated and high-throughput manufacturing platform
Published: April 22, 2024 by Bristol-Myers Squibb Co.
Cellares partners with Bristol Myers to provide automated manufacturing for proof-of-concept CAR-T cell therapy under its TAP program; the collaboration aims to lower manufacturing costs, process failure rates, accelerate production scaling
Published: August 29, 2023 by Cellares integrated development and manufacturing

Ask us about our Transformation & Innovation market view

Trending Chart

Interactive chart with headline count